Sotera Health Co
SHCNasdaqCIK 1822479HealthcareFiscal year ends Dec 31
Reports and events: 113 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1411:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001822479-26-000050 |
| 2026-08-0620:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001822479-26-000047 |
| 2026-08-0611:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-26-000044 |
| 2026-05-2220:09 ET | 8-K | 5.07 Shareholder vote results | 0001822479-26-000034 |
| 2026-05-2020:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-232585 |
| 2026-05-1320:11 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-221630 |
| 2026-05-0520:19 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001822479-26-000031 |
| 2026-05-0511:13 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001822479-26-000028 |
| 2026-04-0820:30 ET | DEF 14A | Proxy statementPeriod 2026-05-21 | 0001104659-26-040937 |
| 2026-03-1611:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001822479-26-000019 |
| 2026-03-0622:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-096983 |
| 2026-02-2421:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001822479-26-000015 |
| 2026-02-2412:14 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001822479-26-000012 |
| 2026-02-0512:35 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001822479-26-000007 |
| 2026-01-1212:24 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822479-26-000004 |
| 2025-11-1021:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-274199 |
| 2025-11-0421:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001822479-25-000054 |
| 2025-11-0412:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-25-000050 |
| 2025-09-1821:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-207549 |
| 2025-09-0520:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-197231 |
| 2025-08-0820:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001822479-25-000044 |
| 2025-08-0811:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-25-000041 |
| 2025-07-2411:31 ET | 8-K | 7.01 Regulation FD disclosure | 0001822479-25-000036 |
| 2025-05-2320:07 ET | 8-K | 5.07 Shareholder vote results | 0001822479-25-000028 |
| 2025-05-0120:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001822479-25-000025 |
| 2025-05-0111:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-25-000022 |
| 2025-04-1011:32 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001104659-25-033563 |
| 2025-04-0411:31 ET | 8-K | 7.01 Regulation FD disclosure | 0001822479-25-000018 |
| 2025-02-2721:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001822479-25-000015 |
| 2025-02-2712:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-25-000012 |
| 2025-01-1412:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822479-25-000006 |
| 2025-01-0621:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001822479-25-000003 |
| 2024-11-2014:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-262222 |
| 2024-11-0521:24 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001822479-24-000049 |
| 2024-11-0512:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-24-000046 |
| 2024-09-0620:36 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-215204 |
| 2024-08-0520:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001822479-24-000041 |
| 2024-08-0511:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-24-000038 |
| 2024-08-0111:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001822479-24-000036 |
| 2024-05-3021:17 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001822479-24-000029 |
| 2024-05-2420:25 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001822479-24-000027 |
| 2024-05-2321:16 ET | 8-K | 7.01 Regulation FD disclosure | 0001822479-24-000024 |
| 2024-05-1620:11 ET | 8-K | 7.01 Regulation FD disclosure | 0001822479-24-000022 |
| 2024-05-0220:40 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001822479-24-000020 |
| 2024-05-0215:57 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-24-000017 |
| 2024-05-0211:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-24-000015 |
| 2024-04-1120:05 ET | DEF 14A | Proxy statementPeriod 2024-05-23 | 0001193125-24-093193 |
| 2024-03-0422:24 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-058025 |
| 2024-02-2721:34 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001822479-24-000011 |
| 2024-02-2712:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001822479-24-000008 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.